Ingredient
Stephania Tetrandra Root Extract
Stephania Tetrandra Root Extract is flagged for pregnancy, breastfeeding, trying to conceive, postpartum, PCOS and general use. The concern behind the strongest flag is insufficient safety data and alkaloid content.
- Fang Ji Extract
- Tetrandrine Source
- Hang Fang Ji
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Stephania Tetrandra Root Extract and pregnancy
Not Recommended
- Insufficient safety data
- Alkaloid content
Stephania Tetrandra Root Extract is a botanical ingredient from traditional Chinese medicine that contains potent alkaloids, including tetrandrine. While it has anti-inflammatory properties that make it attractive for cosmetic use, its safety profile is not well-established for topical application, particularly during pregnancy. The primary concern during pregnancy is the presence of bioactive alkaloids that could potentially have systemic effects if absorbed through the skin. While topical absorption of alkaloids is generally lower than oral consumption, the alkaloids in Stephania tetrandra are known to have biological activity. Oral use of related Aristolochia species has been associated with birth defects and is absolutely contraindicated in pregnancy, though Stephania tetrandra itself is a different plant, historical confusion between these plants raises caution. There are no specific studies on topical use of Stephania Tetrandra Extract during pregnancy, and no regulatory guidance exists because the ingredient is not widely used in Western cosmetics. Given the potent alkaloid content, the lack of safety data, and the serious concerns associated with related botanical species in the Menispermaceae family, most healthcare providers would recommend avoiding this ingredient during pregnancy as a precautionary measure.
Stephania Tetrandra Root Extract and breastfeeding
Not Recommended
- Insufficient safety data
- Alkaloid content
Stephania Tetrandra Extract contains alkaloids that are biologically active compounds. While topical application results in lower systemic absorption than oral consumption, alkaloids can be fat-soluble and potentially accumulate in tissues or transfer to breast milk. There is no data on whether tetrandrine or other alkaloids from topical application of Stephania Tetrandra Extract can transfer to breast milk. Given the known biological activity of these compounds and the potential for infant exposure through milk, the lack of safety data is concerning. Without adequate safety studies and given the potent nature of the plant's alkaloid constituents, most lactation consultants and dermatologists would recommend avoiding this ingredient during breastfeeding. There are many well-studied anti-inflammatory alternatives available that do not carry the same theoretical risks.
Stephania Tetrandra Root Extract and postpartum
Caution Advised
For postpartum women who are not breastfeeding, the primary concern with Stephania Tetrandra Extract is the limited safety data for cosmetic use rather than specific postpartum risks. The anti-inflammatory properties could theoretically benefit postpartum skin concerns, but the lack of toxicological data for topical use raises caution. While the absence of breastfeeding removes concerns about infant exposure, the ingredient's alkaloid content and limited safety profile suggest that more established anti-inflammatory ingredients with better-documented safety records would be preferable choices for postpartum skincare.
Stephania Tetrandra Root Extract and trying to conceive
Not Recommended
- Alkaloid content
Women trying to conceive should approach Stephania Tetrandra Extract with the same caution as pregnant women, since conception can occur before pregnancy is confirmed. The alkaloid content and limited safety data suggest avoiding this ingredient during the periconception period. While there is no specific evidence that topical use affects fertility, the lack of safety studies and the potent bioactive nature of the plant's constituents mean that choosing alternative anti-inflammatory ingredients with established safety profiles is the more prudent approach for women actively trying to conceive.
Stephania Tetrandra Root Extract and PCOS
Caution Advised
Stephania Tetrandra Extract's anti-inflammatory properties could theoretically benefit PCOS-related skin inflammation and acne, but the limited safety data for cosmetic use is a concern. There is no evidence that the ingredient affects hormones or insulin sensitivity. The alkaloid content and lack of comprehensive toxicological studies for topical application mean that women with PCOS should exercise caution. The ingredient does not have specific hormonal concerns relevant to PCOS, but the general safety profile is not well-established. Given that women with PCOS have many well-studied anti-inflammatory options available (niacinamide, azelaic acid, green tea extract), choosing an ingredient with limited safety data provides no clear advantage and introduces unnecessary uncertainty.
Stephania Tetrandra Root Extract and general use
Caution Advised
Stephania Tetrandra Root Extract contains tetrandrine and other alkaloids that have demonstrated anti-inflammatory and antioxidant properties in research contexts. The extract has been used in traditional Chinese medicine, though primarily through oral administration rather than topical application. The main concern for general consumers is the limited safety data specifically for cosmetic use. While the plant's alkaloids have been studied for potential pharmaceutical applications, comprehensive toxicological assessment for topical cosmetic use is lacking. Oral consumption of Stephania species has been associated with potential organ toxicity in some contexts, though topical absorption would be significantly lower. For the general public, the ingredient is not necessarily dangerous but represents an uncertain choice when many well-studied anti-inflammatory botanical extracts are available. Individuals sensitive to alkaloid-containing plants or those who prefer ingredients with established safety profiles may wish to choose alternatives. The ingredient is not banned or restricted in major markets but is also not commonly used in Western cosmetics, partly due to the limited safety documentation.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Stephania Tetrandra Root Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store